Показати скорочений опис матеріалу
dc.contributor.author | Shamrai, Volodymyr Anatoliiovych | |
dc.contributor.author | Misiurko, Oles Ivanovych | |
dc.contributor.author | Grebeniuk, Dmytro Ihorovych | |
dc.date.accessioned | 2025-04-28T15:50:28Z | |
dc.date.available | 2025-04-28T15:50:28Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Shamrai V. A. Features of patients who received chemotherapy for breast cancer / V. A. Shamrai, O. I. Misiurko, D. I. Grebeniuk // Proceedings of VII International Scientific and Practical Conference “Modem directions of scientific research development” (Chicago, USA, December 22-24, 2021). – Chicago: BoScience Publisher, 2021. – P. 80-85. | uk_UA |
dc.identifier.uri | https://dspace.vnmu.edu.ua/123456789/9812 | |
dc.description.abstract | Results of the analysis of the data of 1504 patients who received chemotherapy for breast cancer in the Podillian Regional Oncology Center during 2015-2017 are presented in this article. A detailed analysis of the characteristics of this contingent of patients was carried out. A detailed analysis of data showed that the proportion of women of childbearing age who received chemotherapy as part of comprehensive treatment is 19.93% of all new cases. Among patients receiving chemotherapy, this figure was 28.79%. The most common chemotherapy regimen used in the study contingent was the CAF regimen, which included Cyclophosphamide, Doxorubicin, and 5-Fluorouracil. | uk_UA |
dc.language.iso | en_US | uk_UA |
dc.publisher | BoScience Publisher | uk_UA |
dc.subject | breast cancer | uk_UA |
dc.subject | Podillian Regional Oncology Center | uk_UA |
dc.subject | diagnosis | uk_UA |
dc.subject | treatment | uk_UA |
dc.subject | chemotherapy | uk_UA |
dc.title | Features of patients who received chemotherapy for breast cancer | uk_UA |
dc.type | Thesis | uk_UA |